Offering Executive Summary
Background Information on Issuer
Management Team at Issuer
A 20-year biopharmaceutical industry veteran, Robin was most recently President and CEO of Zacharon Pharmaceuticals where he successfully led the venture-backed startup from financing through new orphan drug program development, multiple new partnerships, and on to a sale of the company last year to BioMarin Pharmaceuticals. Previously Dr. Jackman was Senior Vice President at Vical where he ran the oncology division, which included completing a first-in-human exploratory Phase 1 clinical study, as well as launching and enrolling a Phase 3 worldwide registration clinical trial encompassing over 120 clinical sites in 15 countries. Early in his career he was an investment banker with the life-science unit at BankAmerica Robertson Stephens where he provided strategic and financing services to companies ranging from small venture-backed startups to large multinational pharmaceuticals. Robin holds graduate degrees from Harvard Medical School and Harvard University, and an undergraduate degree from Stanford University.
Mr. Doyle brings 20 years of professional and entrepreneurial experience, which includes senior level business leadership in both public and private companies, strategic management consulting, forming and incubating early to mid-stage companies, mergers & acquisitions, and company management. Prior to joining the Company, Mr. Doyle was the Managing Partner at InLab Ventures, an early-stage venture capital fund based in Southern California. Prior to InLab Ventures, he served as the Division President at UBICS Corporation, a publicly traded IT Consulting and Systems Integration company. Prior to UBICS, Mr. Doyle had a successful strategic management consulting career at both A.T. Kearney and Sapient Corporation. Mr. Doyle consulted for dozens of Fortune 500 companies, including Roche, Caterpillar, Time Warner, Nokia, Hewlett-Packard, Sun Microsystems, GEICO, Progressive, ADM, and General Motors. Mr. Doyle began his career as a member of EDS’s corporate finance and M&A organization. He has played key financial and due diligence roles for dozens of M&A transactions valued at over $3B. In addition to his professional career, Mr. Doyle is also a serial entrepreneur, having started and sold four different businesses from the ground up since 1990. He has successfully raised over $55 million in seed, Series A, and Series B funds for both private investor-held and VC-backed ventures and has raised and managed a $70 million company. Mr. Doyle has an MBA from USC’s Marshall School of Business and an undergraduate degree in Finance from Brigham Young University.
Mr. Rodenrys is the Executive Director of R&D of the corporation and was the CEO and co-Founder of the previous company, Leading Ventures LLC, from its inception in 2005. He has held extensive leadership positions in several significant companies. He has been CEO of SafetyMate Corporation and Chief Operating Officer of ForHealth Technologies. where he was responsible for R&D, manufacturing, quality assurance, customer service and field operations. Before ForHealth Technologies, Mr. Rodenrys served as president of Vistant Corporation, a subsidiary of Cardinal Health (NYSE:CAH), and a Fortune 40 Company. He previously served as Vice President R&D and IT for Pyxis Corporation, a subsidiary of Cardinal Health (NYSE:CAH) and as Vice President Development for MicroMRP, a LAN-based enterprise software company. Mr. Rodenrys is an active member of the San Diego Tech Coast Angels. Additionally, he serves on the review panels for CCAT (Center for the Commercialization of Advanced Technology) and for the von Liebig center at University of California, San Diego. He holds a BS in engineering from Rensselaer Polytechnic Institute (RPI), a master’s in Management Science from US International University (USIU) and an APICS CPIM (American Production & Inventory Control Society: Certified in Production & Inventory Management). He is the co-author of Production and Management Systems for Business, published by Prentice Hall and is the co-inventor on six patents.